Home / Resource Library / Randomized Phase II Study of Brentuximab-Vedotin With High-Dose Chemotherapy in CD30 Positive Lymphoma

Randomized Phase II Study of Brentuximab-Vedotin With High-Dose Chemotherapy in CD30 Positive Lymphoma

Study investigating brentuximab vedotin combined with chemotherapy for treatment of Hodgkin lymphoma.